Molecular Cancer Therapeutics

SJR Rank #1,046H-index: 212SJR: 2.392Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

American Association for Cancer Research Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.61.21.82.4

Subject Categories

  • Cancer ResearchQ1
  • OncologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer, Hypoxia, and MetabolismCancer-related Molecular PathwaysMonoclonal and Polyclonal Antibodies ResearchCancer Genomics and DiagnosticsHER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsCancer Research and TreatmentsPI3K/AKT/mTOR signaling in cancerUbiquitin and proteasome pathwaysProtein Degradation and Inhibitors

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

2022202504590135180

Detailed Information

ISSN

1535-7163, 1538-8514

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

5.55

References per Document

54.57

Coverage

2001-2026

Scope

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.

Metrics from SCImago Journal Rank 2025. View on SCImago